Trial · NCT03226418
Adverse events80
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
41 to 60 of 80
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Syncope | Nervous system disorders | Group I | 0 | 8 | 0 |
| serious | Syncope | Nervous system disorders | Group II | 1 | 65 | 1 |
| serious | Acute kidney injury | Renal and urinary disorders | Group I | 0 | 8 | 0 |
| serious | Acute kidney injury | Renal and urinary disorders | Group II | 1 | 65 | 1 |
| serious | Chronic kidney disease | Renal and urinary disorders | Group I | 0 | 8 | 0 |
| serious | Chronic kidney disease | Renal and urinary disorders | Group II | 1 | 65 | 1 |
| serious | Renal/Urinary disorders - Other | Renal and urinary disorders | Group I | 0 | 8 | 0 |
| serious | Renal/Urinary disorders - Other | Renal and urinary disorders | Group II | 1 | 65 | 1 |
| serious | Dyspnea | Respiratory, thoracic and mediastinal disorders | Group I | 0 | 8 | 0 |
| serious | Dyspnea | Respiratory, thoracic and mediastinal disorders | Group II | 2 | 65 | 2 |
| serious | Hypoxia | Respiratory, thoracic and mediastinal disorders | Group I | 0 | 8 | 0 |
| serious | Hypoxia | Respiratory, thoracic and mediastinal disorders | Group II | 6 | 65 | 6 |
| serious | Pleural effusion | Respiratory, thoracic and mediastinal disorders | Group I | 0 | 8 | 0 |
| serious | Pleural effusion | Respiratory, thoracic and mediastinal disorders | Group II | 1 | 65 | 1 |
| serious | Pulmonary edema | Respiratory, thoracic and mediastinal disorders | Group I | 0 | 8 | 0 |
| serious | Pulmonary edema | Respiratory, thoracic and mediastinal disorders | Group II | 1 | 65 | 1 |
| serious | Respiratory failure | Respiratory, thoracic and mediastinal disorders | Group I | 0 | 8 | 0 |
| serious | Respiratory failure | Respiratory, thoracic and mediastinal disorders | Group II | 1 | 65 | 1 |
| serious | Hematoma | Vascular disorders | Group I | 0 | 8 | 0 |
| serious | Hematoma | Vascular disorders | Group II | 2 | 65 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03226418/events?page=3